Skip to content

Assessing the Usability and Clinical Utility of the Congo Red Dot Test: A Case-control Study

Assessing the Usability and Clinical Utility of the Congo Red Dot Test: A Case-control Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02610972
Enrollment
150
Registered
2015-11-20
Start date
2018-12-01
Completion date
2019-05-30
Last updated
2019-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preeclampsia

Keywords

Congo Red test GV-005

Brief summary

A case-control study will evaluate the clinical utility of the Congo Red test GV-005 in following women with a clinical diagnosis of preeclampsia and clinically healthy women in the postpartum period

Detailed description

A case-control study (n=150) will evaluate the clinical utility of the Congo Red test GV-005 in following women with a clinical diagnosis of preeclampsia and clinically healthy women in the postpartum period. Women with preeclampsia (n=100) (cases) and clinically healthy women (n=50)(controls) who are hospitalized postpartum will be recruited for the trial. All women will be asked to provide a urine sample. Samples will be collected daily during a woman's hospitalization. The Congo Red test GV-005 and a standard urine dipstick proteinuria test will be performed by a lab technician within 72 hours of sample collection. The purpose of this research is to evaluate progression of urine congophilia postpartum by following patients diagnosed with preeclampsia and clinically healthy women.

Interventions

DEVICECongo Red test GV-005

Congo Red test GV-005 test is a simple test has been developed to detect unfolded or misfolded proteins in urine.

Sponsors

International Centre for Diarrhoeal Disease Research, Bangladesh
CollaboratorOTHER
Gynuity Health Projects
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 64 Years
Healthy volunteers
Yes

Inclusion criteria

* Postpartum * Clinical diagnosis of preeclampsia (severe, mild or superimposed) including eclampsia (n=100) OR Clinically healthy (n=50) * Eligible to consent for research * Agree to comply with study procedures * Able to give informed consent

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of Urine Congophilia Using Congo Red Test GV-005within 72 hours of urine sample collectionPrevalence of urine congophilia using Congo Red test GV-005

Countries

Bangladesh, Mexico

Participant flow

Participants by arm

ArmCount
CLINICALLY CONFIRMED PREECLAMPSIA
Women clinically diagnosed with preeclampsia (severe, mild or superimposed) during pregnancy will provide a urine sample in the postpartum period to determine the presence or absence of proteinuria using the Congo Red test GV-005. Congo Red test GV-005: Congo Red test GV-005 test is a simple test has been developed to detect unfolded or misfolded proteins in urine.
100
CLINICALLY HEALTHY
Women with a delivery of a healthy normal baby at term (induction of labor or an elective Caesarean Section) will provide a urine sample in the postpartum period to determine the presence or absence of proteinuria using the Congo Red test GV-005. Congo Red test GV-005: Congo Red test GV-005 test is a simple test has been developed to detect unfolded or misfolded proteins in urine.
50
Total150

Baseline characteristics

CharacteristicCLINICALLY HEALTHYTotalCLINICALLY CONFIRMED PREECLAMPSIA
Age, Continuous24.82 years
STANDARD_DEVIATION 5.08
24.85 years
STANDARD_DEVIATION 5.2
24.86 years
STANDARD_DEVIATION 5.34
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
Bangladesh
50 participants150 participants100 participants
Sex: Female, Male
Female
50 Participants150 Participants100 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 1000 / 50
other
Total, other adverse events
0 / 1000 / 50
serious
Total, serious adverse events
0 / 1000 / 50

Outcome results

Primary

Prevalence of Urine Congophilia Using Congo Red Test GV-005

Prevalence of urine congophilia using Congo Red test GV-005

Time frame: within 72 hours of urine sample collection

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
CLINICALLY CONFIRMED PREECLAMPSIAPrevalence of Urine Congophilia Using Congo Red Test GV-00587 Participants
CLINICALLY HEALTHYPrevalence of Urine Congophilia Using Congo Red Test GV-00518 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026